The Vanguard Group 13D and 13G filings for Black Diamond Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-09 3:33 pm Sale |
2021-12-31 | 13G | Black Diamond Therapeutics, Inc. BDTX |
The Vanguard Group | 1,014,791 2.800% |
-831,171 (-45.03%) |
Filing |
| 2021-02-10 10:39 am Purchase |
2020-12-31 | 13G | Black Diamond Therapeutics, Inc. BDTX |
The Vanguard Group | 1,845,962 5.130% |
1,845,962 (New Position) |
Filing |